sr 48692 has been researched along with sr 48527 in 11 studies
Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (sr 48527) | Trials (sr 48527) | Recent Studies (post-2010) (sr 48527) |
---|---|---|---|---|---|
203 | 3 | 36 | 12 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (81.82) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botto, JM; Chabry, J; Gully, D; Kitabgi, P; Labbé-Jullié, C; Maffrand, JP; Mas, MV; Mazella, J; Vincent, JP | 1 |
Gilmour, B; Navarro, H; Thomas, JB; Warner, KR | 1 |
Gendron, L; Giddings, AM; Gilmour, BP; Longpre, JM; Olepu, S; Runyon, SP; Sarret, P; Thomas, JB; Warner, KR; Wiethe, RW; Zhang, Y | 1 |
Bougault, I; Gully, D; Le Fur, G; Soubrié, P; Souilhac, J; Steinberg, R | 1 |
Deschaintres, S; Gully, D; Kitabgi, P; Labbé-Jullié, C; Le Fur, G | 1 |
Gueudet, C; Gully, D; Le Fur, G; Poncelet, M; Soubrié, P | 1 |
Azzi, M; Betancur, C; Boudin, H; Gully, D; Lepee, I; Mendez-Ubach, M; Rostene, W; Souaze, F | 1 |
Gueudet, C; Le Fur, G; Santucci, V; Soubrié, P; Steinberg, R | 1 |
Barroso, S; Bernassau, JM; Botto, JM; Kitabgi, P; Labbé-Jullié, C; Mazella, J; Nicolas-Etève, D; Reversat, JL | 1 |
Héaulme, M; Le Fur, G; Leyris, R; Soubrié, P | 1 |
Alonso, R; Fournier, M; Fréchin, N; Gnanadicom, H; Le Fur, G; Soubrié, P | 1 |
1 review(s) available for sr 48692 and sr 48527
Article | Year |
---|---|
Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.
Topics: Animals; Behavior, Animal; Brain; Dopamine; Gene Expression Regulation, Developmental; Humans; Mice; Neurotensin; Pyrazoles; Quinolines; Rats; Receptors, Neurotensin; RNA, Messenger; Tissue Distribution | 1997 |
10 other study(ies) available for sr 48692 and sr 48527
Article | Year |
---|---|
[3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Topics: Animals; Binding Sites; Binding, Competitive; Cell Line; Digitonin; Guanosine 5'-O-(3-Thiotriphosphate); Kinetics; Mice; Mutation; Pyrazoles; Quinolines; Radioligand Assay; Rats; Receptors, Neurotensin; Sodium; Transfection | 1995 |
The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.
Topics: Animals; Calcium Signaling; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Protein Binding; Pyrazoles; Quinolines; Receptors, Neurotensin; Structure-Activity Relationship | 2009 |
Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.
Topics: Analgesics; Animals; Calcium; CHO Cells; Cricetulus; Cyclohexanecarboxylic Acids; Drug Partial Agonism; Pyrazoles; Radioligand Assay; Rats; Receptors, Neurotensin; Structure-Activity Relationship | 2014 |
Blockade of neurotensin receptors by the antagonist SR 48692 partially prevents retrograde axonal transport of neurotensin in rat nigrostriatal system.
Topics: Animals; Axonal Transport; Dopamine; Iodine Radioisotopes; Male; Neostriatum; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Substantia Nigra | 1994 |
Effect of the nonpeptide neurotensin antagonist, SR 48692, and two enantiomeric analogs, SR 48527 and SR 49711, on neurotensin binding and contractile responses in guinea pig ileum and colon.
Topics: Animals; Colon; Female; GTP-Binding Proteins; Guinea Pigs; Ileum; In Vitro Techniques; Intestines; Magnesium; Muscle Contraction; Neurotensin; Pyrazoles; Quinolines; Receptors, Neurotensin | 1994 |
Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists.
Topics: Animals; Behavior, Animal; Brain Diseases; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Female; Injections, Intraperitoneal; Mice; Neurotensin; Oxidopamine; Pyrazoles; Quinolines; Sensitivity and Specificity; Spiperone | 1994 |
Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
Topics: Animals; Cell Count; Cerebral Cortex; Dopamine; Limbic System; Male; Membrane Potentials; Microdialysis; Neurons; Neurotensin; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 1997 |
Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cattle; COS Cells; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Pyrazoles; Quinolines; Rats; Receptors, Neurotensin; Sequence Alignment; Structure-Activity Relationship | 1998 |
Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices.
Topics: Adamantane; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine Antagonists; Down-Regulation; Frontal Lobe; Hippocampus; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Neurotensin; Peptide Fragments; Potassium; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Serotonin; Tetrodotoxin | 1998 |
Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain Chemistry; Cocaine; DNA-Binding Proteins; Dopamine Agonists; Dopamine Uptake Inhibitors; Early Growth Response Protein 1; Enkephalins; Gene Expression; Genes, Immediate-Early; Immediate-Early Proteins; In Situ Hybridization; Male; Neostriatum; Neurons; Proto-Oncogene Proteins c-fos; Pyrazoles; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Neurotensin; RNA, Messenger; Transcription Factors | 1999 |